rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1999-10-7
|
pubmed:abstractText |
Fifteen-day praziquantel therapy for parenchymal neurocysticercosis has been shown to be effective. Plasma and cerebrospinal fluid concentrations of praziquantel peak two hours after administration. Maintenance of high concentrations of the drug for six hours may be an adequate therapy for the disease.
|
pubmed:language |
spa
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0016-3813
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
369-72
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:10491891-Adult,
pubmed-meshheading:10491891-Anticestodal Agents,
pubmed-meshheading:10491891-Brain,
pubmed-meshheading:10491891-Drug Therapy, Combination,
pubmed-meshheading:10491891-Female,
pubmed-meshheading:10491891-Humans,
pubmed-meshheading:10491891-Magnetic Resonance Imaging,
pubmed-meshheading:10491891-Male,
pubmed-meshheading:10491891-Middle Aged,
pubmed-meshheading:10491891-Neurocysticercosis,
pubmed-meshheading:10491891-Praziquantel,
pubmed-meshheading:10491891-Prospective Studies,
pubmed-meshheading:10491891-Time Factors,
pubmed-meshheading:10491891-Tomography, X-Ray Computed
|
pubmed:articleTitle |
[A short praziquantel regimen for the treatment of parenchymatous neurocysticercosis].
|
pubmed:affiliation |
Instituto Nacional de Neurología y Neurocirugía MVS, México, D.F.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|